{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:35:22Z","timestamp":1781789722758,"version":"3.54.5"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Human respiratory syncytial virus (RSV) causes acute respiratory infection in individuals of all age groups. It is the most common pathogen identified in infants and young children with acute lower respiratory infection. Although most infants and young children experience mild, cold-like symptoms, some infants develop severe lower respiratory tract disease such as pneumonia and bronchiolitis that may result in an emergency department visit or hospitalization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>In the United States, hospitalization rates have risen during the last decades, and while premature infants with chronic lung disease and congenital heart disease are at increased risk for severe presentations, the majority of hospitalizations occur in previously healthy infants. Until recently, RSV prophylaxis was only available for former preterm infants and those with certain underlying medical conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The need for preventive interventions against RSV is crucial. This paper will provide a review of the vaccine development, the spectrum of RSV prophylaxis, current challenges associated with the cost, insurance coverage and equitable distribution of targeted therapies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001339","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T04:00:09Z","timestamp":1707883209000},"page":"310-314","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Updates on respiratory syncytial virus prophylaxis: the past, present and future"],"prefix":"10.1097","volume":"36","author":[{"given":"Anne","family":"Coates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Sadreameli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,13]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(10)60401-1","article-title":"Respiratory syncytial virus in young children","volume":"375","author":"Hall","year":"2010","journal-title":"Lancet"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Respiratory Virus Global Epidemiology Network; Nair H; RESCEU investigators. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5\u200ayears in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S0950268800050779","article-title":"Acute respiratory illness in the community. Frequency of illness and the agents involved","volume":"110","author":"Monto","year":"1993","journal-title":"Epidemiol Infect"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0022-3476(86)81034-4","article-title":"Acute lower respiratory tract infections in nonhospitalized children","volume":"108","author":"Denny","year":"1986","journal-title":"J Pediatr"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1045-1870(05)80039-1","article-title":"Bronchiolitis: epidemiology, treatment, and prevention","volume":"6","author":"Gruber","year":"1995","journal-title":"Semin Pediatr Infect Dis"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.282.15.1440","article-title":"Bronchiolitis-associated hospitalizations among US children","volume":"282","author":"Shay","year":"1999","journal-title":"JAMA"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"e2023061803","DOI":"10.1542\/peds.2023-061803","article-title":"Palivizumab prophylaxis in infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"152","author":"Caserta","year":"2023","journal-title":"Pediatrics"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-92-22538","article-title":"Recovery of cytopathogenic agent from chimpanzees with coryza","volume":"92","author":"Blount","year":"1956","journal-title":"Proc Soc Exp Biol Med"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/314846","article-title":"A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9","volume":"180","author":"Johnson","year":"1999","journal-title":"J Infect Dis"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/427813","article-title":"Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants","volume":"191","author":"Karron","year":"2005","journal-title":"J Infect Dis"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/CVI.00609-15","article-title":"Brief history and characterization of enhanced respiratory syncytial virus disease","volume":"23","author":"Acosta","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1016\/S2666-5247(23)00195-7","article-title":"First RSV vaccine approvals","volume":"4","author":"Venkatesan","year":"2023","journal-title":"Lancet Microbe"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1186\/s12879-023-08730-x","article-title":"An update on respiratory syncytial virus","volume":"23","author":"Piralla","year":"2023","journal-title":"BMC Infect Dis"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV Illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa2207566","article-title":"Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults","volume":"388","author":"Falsey","year":"2023","journal-title":"N Engl J Med"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:03:15Z","timestamp":1753898595000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001339","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,13]]}}}